The big-time BARDA contracts keep rolling in, this time for infectious disease biotech and Merck partner ModeX Therapeutics. The company has hauled in a $168 million contract from the Biomedical ...
Regeneron is buying in to Modex Therapeutics’ next-generation antibody platform with a $7 million upfront payment and a total potential deal value exceeding $1 billion. The New York-based biopharma ...
2025 Digital Freight Matching Roundtable: From spot chaos to smart capacity AI-driven digital freight matching platforms are transforming the brokerage landscape, helping shippers and carriers ...
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, ...
First participant dosed with novel investigational EBV vaccine targeting multiple viral proteins in Phase I study WESTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO ...
ModeX Therapeutics Inc., an OPKO Health company, announced the formation of a Scientific Advisory Board to support the development of its immunology and oncology pipeline, which includes ...
Road Town, British Virgin Islands--(Newsfile Corp. - October 9, 2023) - LBank Exchange, a global digital asset trading platform, will list Modex (MODEX) on October 10, 2023. For all users of LBank ...
In-person event to feature over 1,000 exhibitors, 200 sessions and keynotes from Home Depot CFO Richard McPhail, Salim Ismail and Dale Earnhardt Jr When the largest manufacturing and supply chain ...
Perhaps a few years from now, the halls of the Georgia World Congress Center will be peppered with humanoid robots the week of Modex. In 2024, however, Digit stands alone at the supply chain show.
36th Annual State of Logistics Report: Navigating uncertainty amid rising costs and global disruptions The 36th Annual State of Logistics (SoL) Report highlights a logistics market tested by economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results